Maral Pharma SRL
1.8 FTEThe score of Maral Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +453 % Total assets +7 % Headcount (avg FTE) +100 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Maral Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
Maral Pharma's financial analysis
- Solvency17.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Maral Pharma
Maral Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0800.104.894
- VAT number
- BE0800104894
- Peppol
- Registered · 0208:0800104894 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Mar 2023
- Registered office
- 6200 Châtelet
- Size
- Micro · 1.8 FTE
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Maral Pharma (SRL) has been based in Châtelet since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 66,284 € and equity of 164,874 €; its revenue is not published. With 1.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 17.9%, below the median of its sector (41.5%).
Companies similar to Maral Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek VESALIUS Retail sale of pharmaceutical products Roeselare · balance sheet 920,748 €
- Yokriphar Retail sale of pharmaceutical products Tienen · balance sheet 919,785 €
- Pharmacie DE Chastre Retail sale of pharmaceutical products Chastre · balance sheet 922,129 €
- COX Retail sale of pharmaceutical products Hasselt · balance sheet 917,941 €
- Holsbeek Deurne Retail sale of pharmaceutical products Antwerp · balance sheet 917,585 €
- Pharmatrente Retail sale of pharmaceutical products Charleroi · balance sheet 924,033 €
- Verdesa Retail sale of pharmaceutical products Opwijk · balance sheet 924,833 €
- Propharma Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet 915,541 €
Frequently asked questions about Maral Pharma
What is the revenue of Maral Pharma?
Maral Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Maral Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0800104894 for Maral Pharma, if the company is VAT-registered. Its company number (CBE) is 0800.104.894.
Where is the registered office of Maral Pharma?
According to the CBE register, the registered office of Maral Pharma is in 6200 Châtelet.
What is the equity of Maral Pharma?
At the close of the 2025 financial year, the equity of Maral Pharma amounts to 164,874 €, a solvency of 17.9% of total assets.
How many people work at Maral Pharma?
1.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Maral Pharma?
The register lists 1 active mandates at Maral Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Maral Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →